On August 13, 2025, 180 Life Sciences Corp. entered into a Sales Agreement with Clear Street LLC to sell up to $500,000,000 worth of its common stock. The shares may be sold through negotiated transactions or as "at the market offerings." The agent, Clear Street LLC, will receive up to 3.0% of the gross sales price per share as compensation. The total number of shares and their price are not specified in the document.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-075972), on August 14, 2025, and is solely responsible for the information contained therein.